Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 12/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | S100A4 | P26447 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.38 |
| ▸ | APEX1 | P27695 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29518493 | 1.00 | PDK2 (0.50) | PDK2THRBTDP1S100A4KDM4E | |
| SCHEMBL13231065 | 0.89 | PDK2 (0.44) | PDK2THRBTDP1S100A4KDM4E | |
| SCHEMBL11705195 | 0.84 | MEN1 (0.52) | THRBS100A4KDM4EMEN1LMNA | |
| SCHEMBL14803820 | 0.83 | PDK2 (0.38) | PDK2THRBTDP1TSHR | |
| SCHEMBL6316881 | 0.81 | PDK2 (0.50) | PDK2THRBTDP1S100A4KDM4E | |
| SCHEMBL29608923 | 0.81 | PDK2 (0.50) | PDK2THRBTDP1S100A4KDM4E | |
| SCHEMBL25362591 | 0.80 | PDK2 (0.50) | PDK2TDP1 | |
| SCHEMBL19764171 | 0.80 | PDK2 (0.59) | PDK2LMNATSHR | |
| SCHEMBL17474764 | 0.80 | PDK2 (0.59) | PDK2TDP1S100A4KDM4EMEN1 | |
| SCHEMBL19885723 | 0.80 | PDK2 (0.64) | PDK2TDP1LMNATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109912937-A | A kind of new-energy automobile power battery insulating heat-conduction material and preparation method thereof | 杨记周 | 2019-06-21 | — | — | CN | claimed |
| CN-109678686-A | A kind of preparation method of anti-hepatitis drug Lei Dipawei key intermediate | 江苏工程职业技术学院 | 2019-04-26 | — | — | CN | claimed |
| EP-3046924-A1 | HEPATITIS C VIRUS INHIBITORS | IDENIX Pharmaceuticals, Inc. (US) | 2016-07-27 | — | — | EP | claimed |
| WO-2015042375-A1 | HEPATITIS C VIRUS INHIBITORS | IDENIX PHARMACEUTICALS, INC. (US) | 2015-03-26 | — | — | WO | claimed |
| US-20240417415-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2024-12-19 | — | — | US | disclosed |
| US-12103942-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2024-10-01 | — | — | US | disclosed |
| CN-117120403-A | Process for separating fluoride | ＵＢＥ株式会社 | 2023-11-24 | — | — | CN | disclosed |
| US-20230366113-A1 | MEMBRANE ELECTRODE ASSEMBLY FOR WATER ELECTROLYSIS, WATER ELECTROLYSIS CELL INCLUDING THE MEMBRANE ELECTRODE ASSEMBLY AND METHOD FOR FABRICATING THE MEMBRANE ELECTRODE ASSEMBLY | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2023-11-16 | — | — | US | disclosed |
| US-20230366113-A1 | MEMBRANE ELECTRODE ASSEMBLY FOR WATER ELECTROLYSIS, WATER ELECTROLYSIS CELL INCLUDING THE MEMBRANE ELECTRODE ASSEMBLY AND METHOD FOR FABRICATING THE MEMBRANE ELECTRODE ASSEMBLY | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2023-11-16 | — | — | US | disclosed |
| WO-2022220231-A1 | METHOD FOR ISOLATING FLUORINATED SUBSTANCE | ＵＢＥ株式会社 | 2022-10-20 | — | — | WO | disclosed |
| EP-3053875-B1 | FLUORINATING AGENT | DAIKIN IND LTD (JP) | 2022-09-28 | — | — | EP | disclosed |
| WO-2022092063-A1 | COMPOSITION FOR FORMING LOW DIELECTRIC CONSTANT RESIN, LOW DIELECTRIC MEMBER, AND ELECTRONIC DEVICE USING SAME | JNC株式会社 | 2022-05-05 | — | — | WO | disclosed |
| US-20030176747-A1 | Process for the production of fluorinated organic compounds and fluorinating agents | DAIKIN INDUSTRIES, LTD. (JP) | 2003-09-18 | — | — | US | disclosed |
| CN-1436159-A | Processes for production of fluorinated organic compounds and fluorinating agent | DAIKIN IND LTD (JP) | 2003-08-13 | — | — | CN | disclosed |
| EP-1304316-A1 | PROCESSES FOR THE PRODUCTION OF FLUORINATED ORGANIC COMPOUNDS AND FLUORINATING AGENTS | Daikin Industries, Ltd. (JP) | 2003-04-23 | — | — | EP | disclosed |
| WO-2002055463-A1 | FLUORINATED AROMATIC COMPOUNDS AND THE USE OF THE SAME IN LIQUID CRYSTAL MIXTURES | CLARIANT INTERNATIONAL LTD. (CH) | 2002-07-18 | — | — | WO | disclosed |
| EP-0730566-B1 | SELECTIVELY FLUORINATED ORGANIC COMPOUNDS | F2 CHEMICALS LTD (GB) | 2001-09-19 | — | — | EP | disclosed |
| US-5789580-A | Selectively fluorinated organic compounds | BRITISH NUCLEAR FUELS PLC (GB) | 1998-08-04 | — | — | US | disclosed |
| EP-0730566-A1 | SELECTIVELY FLUORINATED ORGANIC COMPOUNDS | BNFL FLUOROCHEMICALS LTD. (GB) | 1996-09-11 | — | — | EP | disclosed |
| WO-1996003357-A1 | SELECTIVELY FLUORINATED ORGANIC COMPOUNDS | BNFL FLUOROCHEMICALS LTD. (GB) | 1996-02-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240417415-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | L1CAM, TRPM2, ORAI2 | PDK2 1845/4885THRB 3487/4885TDP1 2190/4885 |
| US-12103942-B2 | Organic electroluminescent materials and devices | L1CAM, TRPM2, ORAI2 | PDK2 1845/4885THRB 3487/4885TDP1 2190/4885 |
| US-20030176747-A1 | Process for the production of fluorinated organic compounds and fluorinating agents | PFAS, AFF4, AFF1 | PDK2 2462/4885THRB 3625/4885TDP1 2061/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.